1. Home
  2. CCK vs ICLR Comparison

CCK vs ICLR Comparison

Compare CCK & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crown Holdings Inc.

CCK

Crown Holdings Inc.

HOLD

Current Price

$95.76

Market Cap

11.5B

Sector

Industrials

ML Signal

HOLD

Logo ICON plc

ICLR

ICON plc

HOLD

Current Price

$137.16

Market Cap

9.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCK
ICLR
Founded
1906
1990
Country
United States
Ireland
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Commercial Physical & Biological Resarch
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5B
9.3B
IPO Year
2003
2001

Fundamental Metrics

Financial Performance
Metric
CCK
ICLR
Price
$95.76
$137.16
Analyst Decision
Buy
Buy
Analyst Count
16
13
Target Price
$121.19
$178.62
AVG Volume (30 Days)
1.0M
981.3K
Earning Date
04-27-2026
05-12-2026
Dividend Yield
1.41%
N/A
EPS Growth
79.72
N/A
EPS
1.56
N/A
Revenue
$11,665,000,000.00
N/A
Revenue This Year
$5.17
N/A
Revenue Next Year
$2.38
N/A
P/E Ratio
$62.51
$12.91
Revenue Growth
N/A
N/A
52 Week Low
$89.21
$66.57
52 Week High
$116.62
$211.00

Technical Indicators

Market Signals
Indicator
CCK
ICLR
Relative Strength Index (RSI) 38.84 70.29
Support Level $93.91 $99.11
Resistance Level $102.17 $193.87
Average True Range (ATR) 2.19 6.72
MACD 0.02 1.66
Stochastic Oscillator 20.42 91.36

Price Performance

Historical Comparison
CCK
ICLR

About CCK Crown Holdings Inc.

Crown Holdings Inc is a producer of metal packaging. The company manufactures beverage cans, metal food cans, and closures, as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Share on Social Networks: